Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)

The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The estimated total program funding is $2 million, with an award ceiling of $850,000 and two expected awards, with the Notice of Funding Opportunity (NOFO) anticipated to be published in Fall 2024, and applications due by late February 2025. For further details, interested applicants should prepare their submissions in advance of the expected application deadline.